Caitlin Cronin
Stock Analyst at Canaccord Genuity
(0.48)
# 2317
Out of 5,291 analysts
24
Total ratings
42.86%
Success rate
3.48%
Average return
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
TELA TELA Bio | Maintains: Buy | 12 7 | 0.96 | 629.17% | 4 | Mar 21, 2025 | |
SNN Smith & Nephew | Maintains: Hold | 27 27 | 26.66 | 1.28% | 1 | Mar 17, 2025 | |
BVS Bioventus | Maintains: Buy | 15 15 | 7.69 | 95.06% | 1 | Mar 17, 2025 | |
AXGN Axogen | Maintains: Strong Buy | 22 26 | 16.41 | 58.44% | 4 | Feb 26, 2025 | |
VCEL Vericel | Maintains: Strong Buy | 64 67 | 39.74 | 68.6% | 3 | Feb 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 3 4 | 2.5 | 60% | 2 | Nov 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 20 20 | 11.51 | 73.76% | 3 | Aug 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 21 16 | 16.25 | -1.54% | 2 | Jul 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Hold | 130 | 101.5 | 28.08% | 1 | Feb 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 73 75 | 35.07 | 113.86% | 1 | Feb 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 79 | 72.86 | 8.43% | 1 | Feb 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 270 12 | 8.45 | 42.01% | 1 | Nov 14, 2023 |